Lataa...
Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib
PURPOSE: Tyrosine kinase inhibitors like sunitinib and sorafenib are commonly used to treat metastatic renal cell cancer patients. Cubilin is a membrane protein expressed in the proximal renal tubule. Cubilin and megalin function together as endocytic receptors mediating uptake of many proteins. The...
Tallennettuna:
| Julkaisussa: | J Cancer Res Clin Oncol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer Berlin Heidelberg
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5427164/ https://ncbi.nlm.nih.gov/pubmed/28260162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-017-2365-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|